US-FDA
approved a new contraceptive device called Kyleena by Bayer Pharmaceuticals
preventing pregnancy for 5 years. [1]
Kyleena
belongs to the category of Long acting contraceptive device (LARC) and will be
available in the market by prescription from October. The small, flexible, plastic
IUD contains 19.5 mg of a progestin hormone levonorgestrel.
According to
recent data the use of long-acting reversible contraception (LARCs) has
increased nearly five-fold in the last decade.
Kyleena or other hormonal
IUCD are marginally more effective than copper IUCD as they better control the
blood flow.
After using Kyleena
for some time, women are likely to experience fewer days of spotting and
bleeding or may experience amenorrhea. Regular period resumes after removal of
the device.
"Data
show that the use of effective, long-acting birth control methods including
intrauterine devices – or IUDs – have helped to reduce unintended pregnancies
in the United States but we still have a long way to go," said Anita
L. Nelson, M.D., Professor and Chair, Obstetrics and Gynecology at Western
University of Health Sciences, Pomona, Calif on Bayer’s website. "Kyleena
is highly effective at preventing pregnancy and may be an appropriate choice
for women who want a low-dose, non-daily birth control method”. [2]
[1] http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.DrugDetails
[2] http://www.bayer.us/en/article.php?id=123025
No comments:
Post a Comment